rp-a501
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 17, 2019 (NCT03882437)
Timeline
Indications
Studied for
Mechanism of action
- Streptococcus pneumoniaeSupplementation
Streptococcus pneumoniae supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06092034 | Phase 2 | Sep 5, 2023 | Rocket Pharma Limited, University of California, San Diego, University of Pennsylvania |
| NCT03882437 | Phase 1 | Apr 17, 2019 | Rocket Pharma Limited |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rocket Pharma Limited | For profit | 2 | 2 | 2 | 2019 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1